Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells

Journal of Biological Chemistry

Volumn 287, Issue 42, 2012, Pages 35251-35259

  Epis, Michael R ^a   Giles, Keith M ^a   Kalinowski, Felicity C ^a   Barker, Andrew ^a   Cohen, Ronald J ^a,b   Leedman, Peter J ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Uropath Pty Ltd   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYSIS; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CHEMICAL ACTIVATION; DISEASES; ENZYMES; GROWTH KINETICS; UROLOGY;

EUKARYOTIC TRANSLATION; HUMAN PROSTATE CANCER; INVERSE RELATIONSHIP; PROSTATE CANCER CELLS; PROTEIN EXPRESSIONS; QUANTITATIVE RT-PCR; REPORTER GENE ASSAYS; UNTRANSLATED REGIONS;

CELLS;

DEOXYHYPUSINE; DEOXYHYPUSINE HYDROXYLASE; INITIATION FACTOR 5A; MESSENGER RNA; MICRORNA; MICRORNA 331 3P; MICRORNA 642 5P; MIMOSINE; OXYGENASE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; AGED; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BIOINFORMATICS; CANCER CELL; CANCER INHIBITION; CATALYSIS; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENTIATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84867408652     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.374686     Document Type: Article

References (57)

1. Caraglia, M., Park, M. H., Wolff, E. C., Marra, M., and Abbruzzese, A. (2011) Amino Acids [Epub ahead of print]
2. Park, M. H., Nishimura, K., Zanelli, C. F., and Valentini, S. R. (2010) Functional significance of eIF5A and its hypusine modification in eukaryotes. Amino Acids 38, 491-500
3. Chen, K. Y., and Liu, A. Y. (1997) Biochemistry and function of hypusine formation on eukaryotic initiation factor 5A. Biol. Signals 6, 105-109 (Pubitemid 27380000)
4. Park, M. H., Wolff, E. C., and Folk, J. E. (1993) Hypusine: Its post-translational formation in eukaryotic initiation factor 5A and its potential role in cellular regulation. Biofactors 4, 95-104 (Pubitemid 23218841)
5. Kemper, W. M., Merrick, W. C., Redfield, B., Liu, C. K., and Weissbach, H. (1976) Purification and properties of rabbit reticulocyte elongation factor 1. Arch. Biochem. Biophys. 174, 603-612
6. Benne, R., and Hershey, J. W. (1978) The mechanism of action of protein synthesis initiation factors from rabbit reticulocytes. J. Biol. Chem. 253, 3078-3087 (Pubitemid 8353180)
7. Kang, H. A., and Hershey, J. W. (1994) Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae. J. Biol. Chem. 269, 3934-3940 (Pubitemid 24237736)
8. Hanauske-Abel, H. M., Slowinska, B., Zagulska, S., Wilson, R. C., Staiano- Coico, L., Hanauske, A. R., McCaffrey, T., and Szabo, P. (1995) Detection of a subset of polysomal mRNAs associated with modulation of hypusine formation at the G1-S boundary. Proposal of a role for eIF-5A in onset of DNA replication. FEBS Lett. 366, 92-98
9. Cracchiolo, B. M., Heller, D. S., Clement, P. M., Wolff, E. C., Park, M. H., and Hanauske-Abel, H. M. (2004) Eukaryotic initiation factor 5A-1 (eIF5A-1) as a diagnostic marker for aberrant proliferation in intraepithelial neoplasia of the vulva. Gynecol Oncol. 94, 217-222 (Pubitemid 38950524)
10. Park, J. H., Aravind, L., Wolff, E. C., Kaevel, J., Kim, Y. S., and Park, M. H. (2006) Molecular cloning, expression, and structural prediction of deoxyhypusine hydroxylase: A HEAT-repeat-containing metalloenzyme. Proc. Natl. Acad. Sci. U.S.A. 103, 51-56 (Pubitemid 43076103)
11. Hanauske-Abel, H. M., Park, M. H., Hanauske, A. R., Popowicz, A. M., Lalande, M., and Folk, J. E. (1994) Inhibition of the G1-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation. Biochim. Biophys. Acta 1221, 115-124 (Pubitemid 24103809)
12. Park, M. H., Lee, Y. B., and Joe, Y. A. (1997) Hypusine is essential for eukaryotic cell proliferation. Biol. Signals 6, 115-123 (Pubitemid 27380002)
13. Balabanov, S., Gontarewicz, A., Ziegler, P., Hartmann, U., Kammer, W., Copland, M., Brassat, U., Priemer, M., Hauber, I., Wilhelm, T., Schwarz, G., Kanz, L., Bokemeyer, C., Hauber, J., Holyoake, T. L., Nordheim, A., and Brümmendorf, T. H. (2007) Hypusination of eukaryotic initiation factor 5A (eIF5A): A novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach. Blood 109, 1701-1711 (Pubitemid 46239605)
14. Chung, L. C., Tsui, K. H., Feng, T. H., Lee, S. L., Chang, P. L., and Juang, H. H. (2012) L-Mimosine blocks cell proliferation via upregulation of Bcell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells. Am. J. Physiol. Cell Physiol. 302, C676-685
15. Wartenberg, M., Fischer, K., Hescheler, J., and Sauer, H. (2002) Modulation of intrinsic P-glycoprotein expression in multicellular prostate tumor spheroids by cell cycle inhibitors. Biochim. Biophys. Acta 1589, 49-62 (Pubitemid 34242901)
16. Kulp, K. S., and Vulliet, P. R. (1996) Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells. Toxicol. Appl. Pharmacol. 139, 356-364 (Pubitemid 26281613)
17. Chang, H. C., Weng, C. F., Yen, M. H., Chuang, L. Y., and Hung, W. C. (2000) Modulation of cell cycle regulatory protein expression and suppression of tumor growth by mimosine in nude mice. Int. J. Oncol 17, 659-665
18. Zalatnai, A. (2005) P-glycoprotein expression is induced in human pancreatic cancer xenografts during treatment with a cell cycle regulator, mimosine. Pathol Oncol Res. 11, 164-169
19. Cook, J. (2001) Radiation sensitization of mammalian cells by metal chelators. Radiat. Res. 155, 304-310
20. Bartel, D. P. (2004) MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116, 281-297
21. Humphreys, D. T., Westman, B. J., Martin, D. I., and Preiss, T. (2005) MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc. Natl. Acad. Sci. U.S.A. 102, 16961-16966 (Pubitemid 41692666)
22. Chen, J. F., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., Conlon, F. L., and Wang, D. Z. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38, 228-233 (Pubitemid 43177239)
23. Cheng, A. M., Byrom, M. W., Shelton, J., and Ford, L. P. (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 33, 1290-1297 (Pubitemid 41439922)
24. Bueno, M. J., and Malumbres, M. (2011) MicroRNAs and the cell cycle. Biochim. Biophys. Acta 1812, 592-601
25. Zhang, B., Pan, X., Cobb, G. P., and Anderson, T. A. (2007) microRNAs as oncogenes and tumor suppressors. Dev. Biol. 302, 1-12 (Pubitemid 46096921)
26. Esquela-Kerscher, A., and Slack, F. J. (2006) Oncomirs: microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269
27. Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., and Slack, F. J. (2005) RAS is regulated by the let-7 microRNA family. Cell 120, 635-647 (Pubitemid 40343076)
28. Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y., Mitsudomi, T., and Takahashi, T. (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64, 3753-3756 (Pubitemid 38697282)
29. Volinia, S., Calin, G. A., Liu, C. G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., Prueitt, R. L., Yanaihara, N., Lanza, G., Scarpa, A., Vecchione, A., Negrini, M., Harris, C. C., and Croce, C. M. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U.S.A. 103, 2257-2261 (Pubitemid 43271657)
30. Si, M. L., Zhu, S., Wu, H., Lu, Z., Wu, F., and Mo, Y. Y. (2007) miR-21-mediated tumor growth. Oncogene 26, 2799-2803 (Pubitemid 46663837)
31. Epis, M. R., Giles, K. M., Barker, A., Kendrick, T. S., and Leedman, P. J. (2009) miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer. J. Biol. Chem. 284, 24696-24704
32. Epis, M. R., Barker, A., Giles, K. M., Beveridge, D. J., and Leedman, P. J. (2011) The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells. J. Biol. Chem. 286, 41442-41454
33. Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-ΔΔC(T)) method. Methods 25, 402-408 (Pubitemid 34164012)
34. Giles, K. M., Barker, A., Zhang, P. M., Epis, M. R., and Leedman, P. J. (2011) MicroRNA regulation of growth factor receptor signaling in human cancer cells. Methods Mol. Biol. 676, 147-163
35. Bliss, C. (1939) The toxicity of poisons applied jointly. Ann. Appl. Biol. 26, 585-615
36. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (Pubitemid 40094598)
37. Grimson, A., Farh, K. K., Johnston, W. K., Garrett-Engele, P., Lim, L. P., and Bartel, D. P. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91-105 (Pubitemid 46991392)
38. Guo, X., Guo, L., Ji, J., Zhang, J., Zhang, J., Chen, X., Cai, Q., Li, J., Gu, Q., Liu, B., Zhu, Z., and Yu, Y. (2010) miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Biochem. Biophys. Res. Commun. 398, 1-6
39. Wang, L., Tang, H., Thayanithy, V., Subramanian, S., Oberg, A. L., Cunningham, J. M., Cerhan, J. R., Steer, C. J., and Thibodeau, S. N. (2009) Gene networks and microRNAs implicated in aggressive prostate cancer. Cancer Res. 69, 9490-9497
40. White, N. M., Youssef, Y. M., Fendler, A., Stephan, C., Jung, K., and Yousef, G. M. (2012) The miRNA-kallikrein axis of interaction: A new dimension in the pathogenesis of prostate cancer. Biol. Chem. 393, 379-389
41. Xu, G., Wu, J., Zhou, L., Chen, B., Sun, Z., Zhao, F., and Tao, Z. (2010) Characterization of the small RNA transcriptomes of androgen-dependent and -independent prostate cancer cell line by deep sequencing. PLoS One 5, e15519
42. John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., and Marks, D. S. (2004) Human MicroRNA targets. PLoS Biol. 2, e363
43. Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., and Rajewsky, N. (2005) Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500 (Pubitemid 40617277)
44. Witkos, T. M., Koscianska, E., and Krzyzosiak, W. J. (2011) Practical aspects of microRNA target prediction. Curr. Mol. Med. 11, 93-109
45. Webster, R. J., Giles, K. M., Price, K. J., Zhang, P. M., Mattick, J. S., and Leedman, P. J. (2009) Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA-7. J. Biol. Chem. 284, 5731-5741
46. Guo, H., Ingolia, N. T., Weissman, J. S., and Bartel, D. P. (2010) Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840
47. Chi, S. W., Zang, J. B., Mele, A., and Darnell, R. B. (2009) Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460, 479-486
48. Jackson, R. J., and Standart, N. (2007) How do microRNAs regulate gene expression? Sci. STKE 2007, re1
49. Maes, O. C., Sarojini, H., and Wang, E. (2009) Stepwise up-regulation of microRNA expression levels from replicating to reversible and irreversible growth arrest states in WI-38 human fibroblasts. J. Cell. Physiol. 221, 109-119
50. Wang, L., Oberg, A. L., Asmann, Y. W., Sicotte, H., McDonnell, S. K., Riska, S. M., Liu, W., Steer, C. J., Subramanian, S., Cunningham, J. M., Cerhan, J. R., and Thibodeau, S. N. (2009) Genome-wide transcriptional profiling reveals microRNA-correlated genes and biological processes in human lymphoblastoid cell lines. PLoS One 4, e5878
51. Engelmann, D., and Pützer, B. M. (2012) The dark side of E2F1: In transit beyond apoptosis. Cancer Res. 72, 571-575
52. Lee, K. H., Chen, Y. L., Yeh, S. D., Hsiao, M., Lin, J. T., Goan, Y. G., and Lu, P. J. (2009) MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Oncogene 28, 3360-3370
53. Hoque, M., Hanauske-Abel, H. M., Palumbo, P., Saxena, D., D'Alliessi Gandolfi, D., Park, M. H., Pe'ery, T., and Mathews, M. B. (2009) Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A. Retrovirology 6, 90
54. Maier, B., Ogihara, T., Trace, A. P., Tersey, S. A., Robbins, R. D., Chakrabarti, S. K., Nunemaker, C. S., Stull, N. D., Taylor, C. A., Thompson, J. E., Dondero, R. S., Lewis, E. C., Dinarello, C. A., Nadler, J. L., and Mirmira, R. G. (2010) The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice. J. Clin. Invest. 120, 2156-2170
55. Guan, X. Y., Fung, J. M., Ma, N. F., Lau, S. H., Tai, L. S., Xie, D., Zhang, Y., Hu, L., Wu, Q. L., Fang, Y., and Sham, J. S. (2004) Oncogenic role of eIF-5A2 in the development of ovarian cancer. Cancer Res. 64, 4197-4200 (Pubitemid 38802423)
56. Xie, D., Ma, N. F., Pan, Z. Z., Wu, H. X., Liu, Y. D., Wu, G. Q., Kung, H. F., and Guan, X. Y. (2008) Overexpression of EIF-5A2 is associated with metastasis of human colorectal carcinoma. Hum. Pathol. 39, 80-86 (Pubitemid 350216163)
57. Preukschas, M. H., Schulte, A., Lamszus, K., Sievert, H., Bokemeyer, C., and Balabanov, S. (2011) Overexpression of eukaryotic initiation factor 5a (eIF-5A) and hypusine-forming enzymes in glioblastoma patient samples and therapeutic potential of hypusine modification for treatment of glioblastoma multiforme in 2011 European Multidisciplinary Cancer Congress, Vol. 47, Suppl. 1, Sept. 2011, p. 157, Elsevier